Results 61 to 70 of about 147,441 (251)
"Regulating Healthcare Technologies and Medical Supplies: A Comparative Overview" [PDF]
, 1995 A complex relationship exists among EU regulations, current national practices and rules, institutional capacities to implement regulatory adjustments and the legacy of past health and regulatory policy and traditions.
Altenstetter, Christa.
core
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Journal of Evidence Based Health Policy, Management & Economics, 2022 Background: The most well-known classification of the cost of diseases is direct medical cost. The aim of this study is to investigate and analyze direct treatment costs of patients with Covid-19 by hospitals affiliated with Ilam University of Medical ...
Fereshteh Karimi +4 more
doaj
Demand for Pharmaceuticals: Impacts on Production and Employment in Nearly Every Sector of the Economy [PDF]
The pharmaceutical industry employs around 106 000 people and produces a good 9 billion euros or 2.5% of value added in the manufacturing sector in Germany.
Joachim Schintke +2 more
core
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
“Health inequalities in Armenia - analysis of survey results”
International Journal for Equity in Health, 2012 Introduction Prevailing sociopolitical and economic obstacles have been implicated in the inadequate utilization and delivery of the Armenian health care system. Methods A random survey of 1,000 local residents, from all administrative regions of Armenia,
Tonoyan Tamara, Muradyan Lusine
doaj +1 more source
The Impact of Healthcare Spending on Health Outcomes: New Evidence from OECD Countries
Erciyes Medical Journal, 2020 Objective: This study aimed to reveal the impact of the selected healthcare spending indicators on the selected health outcomes for OECD countries.
Sevilay Karaman +4 more
doaj +1 more source
, 2005 The pharmaceutical industry employs around 106 000 people and produces a good 9 billion euros or 2.5% of value added in the manufacturing sector in Germany.
Raab, Stephan +2 more
core
Changing healthcare systems in Asia [PDF]
, 2004 Outline of key changes in healthcare systems in Asia including company developments and trade union ...
Lethbridge, Jane
core
British Journal of Clinical Pharmacology, EarlyView.Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source